文献速递儿童呼吸儿童感染

儿童医疗复杂性社区获得性肺炎的抗生素选择

Antibiotic Choice for Community-Acquired Pneumonia in Children With Medical Complexity.
PubMed 文献 · Pediatrics · 2026-01-01

本研究采用目标试验模拟的队列设计,纳入2016年1月至2024年4月期间847次(749例)3月龄至21岁儿童医疗复杂性(CMC)住院,比较初始广谱与窄谱抗生素对非重症社区获得性肺炎(CAP)的疗效。结果显示广谱抗生素在至出院时间、进展为重症CAP及30天CAP相关再就诊方面与窄谱抗生素无显著差异,支持在许多CMC的非重症CAP中使用氨基青霉素。

要点

  • 在CMC非重症CAP住院患儿中,初始广谱抗生素未改善临床结局。
  • 广谱与窄谱组至出院时间、重症进展及30天再就诊风险均无显著差异。
  • 结果支持在许多CMC非重症CAP中使用氨基青霉素。

核心结论

  • 在CMC非重症CAP住院患儿中,初始广谱抗生素相比窄谱抗生素未改善临床结局,支持在许多CMC中使用氨基青霉素。

研究设计与样本

  • 采用目标试验模拟的队列研究,在学术健康系统内纳入2016年1月至2024年4月期间847次住院(749例患者),年龄3月龄至21岁,具CAP及复杂慢性病ICD-10编码且接受抗生素≥3天。
  • 排除重症/复杂性CAP、慢性肺部疾病、镰状细胞病、气管造口、免疫抑制、其他细菌感染或近期CAP住院者。
  • 暴露为就诊12小时内初始广谱抗生素(除氨基青霉素外的CAP抗生素),主要结局为至出院时间(第10天删失),次要结局为进展为重症CAP及30天CAP相关再就诊。
  • 采用逆概率治疗加权调整混杂,至出院时间用Royston-Parmar灵活生存模型,二分类结局用逻辑回归。

主要发现

  • 加权并修剪后742次住院达到协变量平衡。
  • 广谱组与窄谱组至出院时间无显著差异(风险比0.84;95%CI 0.68-1.04)。
  • 广谱组与窄谱组进展为重症CAP无显著差异(OR 1.29;95%CI 0.7-2.4)。
  • 广谱组与窄谱组30天CAP相关再就诊无显著差异(OR 0.39;95%CI 0.1-1.2)。

关键数值与推荐

  • 非重症CAP定义为无重症/复杂性CAP且符合纳入标准。
  • 初始广谱抗生素定义为就诊12小时内使用除氨基青霉素外的CAP抗生素。
  • 主要结局至出院时间在第10天删失。
  • 进展为重症CAP及30天CAP相关再就诊为次要结局。

临床怎么用

  • 对于CMC住院的非重症CAP患儿,初始广谱抗生素未显示优于窄谱抗生素,可考虑使用氨基青霉素。
  • 临床决策仍需结合患儿具体情况,但本研究结果支持窄谱抗生素在许多CMC非重症CAP中的应用。

局限性

  • 本研究为观察性队列模拟目标试验,可能存在残余混杂。
  • 结果基于学术健康系统数据,外推需谨慎。
  • 排除重症/复杂性CAP及其他特定合并症患儿,结论不适用于这些人群。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: There are no guideline recommendations for antibiotic choice for community-acquired pneumonia (CAP) in children with medical complexity (CMC). We compared broad- vs narrow-spectrum antibiotics in CMC hospitalized with nonsevere CAP. METHODS: This cohort study was conducted using target trial emulation within an academic health system. We included hospitalizations from January 2016 to April 2024 with International Classification of Diseases, 10th Revision (ICD-10) codes for CAP and complex chronic conditions among children aged 3 months to 21 years who received 3 or more days of antibiotics. We excluded children with severe/complicated CAP, chronic pulmonary conditions, sickle cell disease, tracheostomies, immunosuppression, other bacterial infections, or recent CAP admission. The exposure was initial broad-spectrum antibiotics (CAP antibiotics other than aminopenicillins) within 12 hours of presentation. The primary outcome was time to discharge, censored at day 10. Secondary outcomes were progression to severe CAP and 30-day CAP-related revisits. To mitigate confounding, we applied inverse probability of treatment weighting in outcome models, including a Royston-Parmar flexible survival model for time to discharge, and logistic regression for binary outcomes. RESULTS: A total of 847 encounters (749 patients) were included. After weighting and trimming, 742 encounters remained with adequate covariate balance. Compared with the narrow-spectrum group, the broad-spectrum group demonstrated no significant differences in time to discharge (hazard ratio, 0.84; 95% CI, 0.68-1.04), progression to severe CAP (odds ratio [OR], 1.29; 95% CI, 0.7-2.4), or 30-day CAP-related revisits (OR, 0.39; 95% CI, 0.1-1.2). CONCLUSIONS: In CMC hospitalized with nonsevere CAP, initial broad-spectrum antibiotics did not improve clinical outcomes compared with narrow-spectrum antibiotics, supporting the use of aminopenicillins for nonsevere CAP in many CMC.

来源:Pediatrics,查看原文。版权归原作者所有。

引用

  1. Ekambaram M, Li Y, Thomson J, et al. Antibiotic Choice for Community-Acquired Pneumonia in Children With Medical Complexity. Pediatrics. 2026. PMID: 42838530. doi:10.1542/peds.2026-076178

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。